Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Repost of TPL's concerns about the current stay

OK Ease I'm with you now, but I still think TPL should not drop the 749 and 148. It is my hope that the USPTO is aware of the stay and they may be trying to complete the review faster than normal because they are holding up the case. It may help light a fire under the USPTO.

All the best,

Steve

Share
New Message
Please login to post a reply